SCHEMBL25388252

SCHEMBL25388252

NC(O)(F)CCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9437327 0.86 LMNA (0.47)
SCHEMBL9438240 0.81 LMNA (0.42)
SCHEMBL866140 0.81 LMNA (0.42)
SCHEMBL9438155 0.79 LMNA (0.40)
SCHEMBL442849 0.78
SCHEMBL9789573 0.77 CYP1A2 (0.50)
SCHEMBL3698957 0.77 LMNA (0.38)
Hydrochloric Acid SCHEMBL10381442 0.77 LMNA (0.38)
SCHEMBL9789574 0.77 CYP1A2 (0.50)
SCHEMBL866227 0.77 LMNA (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4486753-B1 BROAD SPECTRUM AMINOGLYCOSIDES AND USES THEREOF REVAGENIX INC (US) 2026-05-13 EP disclosed
US-20250032524-A1 BROAD SPECTRUM AMINOGLYCOSIDES AND USES THEREOF REVAGENIX INC (US) 2025-01-30 US disclosed
EP-4486753-A1 BROAD SPECTRUM AMINOGLYCOSIDES AND USES THEREOF Revagenix, Inc. (US) 2025-01-08 EP disclosed
WO-2023166488-A1 BROAD SPECTRUM AMINOGLYCOSIDES AND USES THEREOF REVAGENIX, INC. (US) 2023-09-07 WO disclosed